Venture Valuation
Consultancy that provides independent valuation and business development services for life-science companies (biotech, pharmaceutical, medtech). Offers company and product valuation, investor reporting and fairness opinions, partner search and licensing advisory, a life-science BD&L database and digital partnering platforms, and workshops on valuation and financing. Headquartered in Zurich, Switzerland.
Industries
N/A
Nr. of Employees
small (1-50)
Venture Valuation
Products
BD&L business-development database
Global BD&L database covering tens of thousands of life-science companies with structured data on assets, clinical trials, financing rounds and licensing activities.
Digital partnering platform
Platform to support digital partnering activities and virtual partnering events for pharma, biotech, medtech and digital health companies.
Conference and matchmaking platform
Solution for conference matchmaking usable on-site, virtually or in hybrid formats to support partnering events.
BD&L business-development database
Global BD&L database covering tens of thousands of life-science companies with structured data on assets, clinical trials, financing rounds and licensing activities.
Digital partnering platform
Platform to support digital partnering activities and virtual partnering events for pharma, biotech, medtech and digital health companies.
Conference and matchmaking platform
Solution for conference matchmaking usable on-site, virtually or in hybrid formats to support partnering events.
Services
Tailored valuation engagement for life-science companies producing independent valuation reports for negotiations and financing.
Independent product and IP valuation report including assessment of licensing deal structures and financial impact.
Monitoring, reporting and NAV calculation for investors, plus fairness opinions and arbitration support.
Targeted partner search and licensing advisory leveraging global networks and a curated BD&L database.
Interactive workshops on valuation and financing available virtually, on-site, or in-house.
Tailored valuation engagement for life-science companies producing independent valuation reports for negotiations and financing.
Independent product and IP valuation report including assessment of licensing deal structures and financial impact.
Monitoring, reporting and NAV calculation for investors, plus fairness opinions and arbitration support.
Targeted partner search and licensing advisory leveraging global networks and a curated BD&L database.
Interactive workshops on valuation and financing available virtually, on-site, or in-house.
Expertise Areas
- Company valuation for biotech, pharma and medtech
- Product and IP valuation
- Business development and licensing (BD&L)
- Investor reporting and net asset valuation
Key Technologies
- Business-development and licensing (BD&L) database
- Digital partnering / matchmaking platform
- Cloud-based data platform (inferred)
- Financial modelling and discounted cash-flow analysis
News & Updates
Upcoming industry showcase event listed on the company events page.
Listed upcoming event on company events page.
Presentation on valuing biotech companies for financing and partnering at Biotech Summit Austria 2025.
Presentation about company valuation at World Vaccine Congress Europe 2025.
Upcoming industry showcase event listed on the company events page.
Listed upcoming event on company events page.
Presentation on valuing biotech companies for financing and partnering at Biotech Summit Austria 2025.
Presentation about company valuation at World Vaccine Congress Europe 2025.